期刊
FRONTIERS IN BIOSCIENCE-LANDMARK
卷 7, 期 -, 页码 C44-+出版社
FRONTIERS IN BIOSCIENCE INC
DOI: 10.2741/bankert
关键词
cancer therapy; immunotherapy; human cancer; SCID mouse; chimeric animal models; human-tumor xenografts; drug delivery; cytokines; cancer vaccines; review
资金
- NATIONAL CANCER INSTITUTE [R01CA079879, P30CA016056, R01CA075235, R01CA054491, R01CA033462] Funding Source: NIH RePORTER
- NCI NIH HHS [CA54491, 5P30CA16056-25, CA33462, CA79879, CA75235] Funding Source: Medline
The successful engraftment of human tumors and human immunocompetent cells into severe combined immunodeficient (SCID) mice has led to the generation of a wide array of different experimental designs that have proven useful in studying the cell biology of human cancer, and for evaluating novel therapeutic approaches to the treatment of cancer. In this review five of the most frequently used embodiments of the SCID model are presented. The goals of this review are to discuss how each model has been utilized to study human cancer and its response to many different novel therapies, to provide an assessment of the strengths and limitations of each model, and to outline future directions with a focus on what is needed to overcome some of the current limitations and pitfalls of the SCID models.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据